ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS
申请人:PURDUE RESEARCH FOUNDATION
公开号:US20150148370A1
公开(公告)日:2015-05-28
The invention described herein pertains to substituted indenoisoquinoline compounds as described herein, wherein R
A
, R
D
, W, X and Y are defined herein, pharmaceutical compositions and formulations comprising the indenoisoquinoline compounds, their synthesis, and methods for their use in the treatment and/or prevention of cancer.
US9328073B2
申请人:——
公开号:US9328073B2
公开(公告)日:2016-05-03
US9682990B2
申请人:——
公开号:US9682990B2
公开(公告)日:2017-06-20
Alcohol-, Diol-, and Carbohydrate-Substituted Indenoisoquinolines as Topoisomerase I Inhibitors: Investigating the Relationships Involving Stereochemistry, Hydrogen Bonding, and Biological Activity
作者:Katherine E. Peterson、Maris A. Cinelli、Andrew E. Morrell、Akhil Mehta、Thomas S. Dexheimer、Keli Agama、Smitha Antony、Yves Pommier、Mark Cushman
DOI:10.1021/jm101338z
日期:2011.7.28
topoisomerase I (Top1) can be inhibited by heterocyclic compounds such as indolocarbazoles and indenoisoquinolines. Carbohydrate and hydroxyl-containing side chains are essential for the biological activity of indolocarbazoles. The current study investigated how similar functionalities could be “translated” to the indenoisoquinoline system and how stereochemistry and hydrogenbonding affect biological